Analyst Ratings for Harmony Biosciences Holdings Inc. (HRMY)
HRMY Rating Summary
HRMY Price Target Summary
- Highest: $70.00 (Oppenheimer)
- Lowest: $28.00 (BofA Securities)
- Average: $44.73
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$44.73 (+8.4%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 73%
Avg. $ Target:
$44.73 (+8.4%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 73%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/26/2026 | Wolfe Research | Rudy Li | New Coverage | Outperform (N/A) |
60.00 (N/A) |
38.95 (41.25) |
5.91% | Details |
| 2/23/2026 | Deutsche Bank | David Hoang | Downgrade | Hold (Buy) |
31.00 (47.00) |
29.16 (41.25) |
41.46% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
